Builder Investment Group Inc. ADV purchased a new position in AT&T Inc. (NYSE:T – Get Rating) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 44,622 shares of the technology company’s stock, valued at approximately $821,000. A number of other institutional investors also recently made changes to […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) insider Merdad Parsey sold 1,485 shares of the business’s stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $76.90, for a total transaction of $114,196.50. Following the sale, the insider now directly owns 29,402 shares in the company, valued at […]
Chesapeake Wealth Management lowered its position in shares of AT&T Inc. (NYSE:T – Get Rating) by 6.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 30,740 shares of the technology company’s stock after selling 1,983 shares during the quarter. Chesapeake Wealth Management’s […]
Adams Wealth Management grew its holdings in shares of AT&T Inc. (NYSE:T – Get Rating) by 29.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,658 shares of the technology company’s stock after purchasing an additional 5,815 shares during the […]
Cognios Beta Neutral Large Cap Fund LP purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 14,135 shares of the biopharmaceutical company’s stock, valued at approximately $1,213,000. Gilead Sciences accounts […]